These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10803732)

  • 1. Dopamine in heart failure and critical care.
    Smit AJ
    Clin Exp Hypertens; 2000 Apr; 22(3):269-76. PubMed ID: 10803732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibopamine--how should it be used?
    Bussmann WD; Wienhöfer K; Frik R
    Cardiology; 1988; 75 Suppl 1():126-37. PubMed ID: 3069210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of ibopamine in patients with chronic heart failure.
    Metra M; Dei Cas L
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I22-31. PubMed ID: 7743695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T; Isaka N; Konishi T; Tekezawa H; Morimoto Y; Kakuta Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F; Morgera T; Maras P; Camerini F
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic evaluation of ibopamine in severe congestive heart failure.
    Reffo GC; Turrin M; Gabellini A; Forattini C
    Eur J Clin Pharmacol; 1984; 26(1):19-22. PubMed ID: 6714289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
    Marchionni N; Conti A; De Alfieri W; Di Bari M; Ferrucci L; Lombardi A; Moschi G; Vannucci A
    J Clin Pharmacol; 1986 Jan; 26(1):74-7. PubMed ID: 3512618
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure.
    Ungar A; Fumagalli S; Marini M; Di Serio C; Tarantini F; Boncinelli L; Baldereschi G; Valoti P; La Cava G; Olianti C; Masotti G; Marchionni N
    Crit Care Med; 2004 May; 32(5):1125-9. PubMed ID: 15190961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibopamine and survival in severe congestive heart failure: PRIME II.
    Girbes AR; Zijlstra JG
    Lancet; 1997 Jul; 350(9071):147-8. PubMed ID: 9228993
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of adrenergic and dopamine receptors.
    Goldberg LI; Rajfer SI
    Hosp Pract (Off Ed); 1985 Jun; 20(6):67-80. PubMed ID: 2861208
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
    Col J; Mievis E; Reynaert M
    Eur J Clin Pharmacol; 1983; 24(3):297-300. PubMed ID: 6861844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.